Bingyang Hu
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 7
- Pancreatic and Hepatic Oncology Research 4
- Cancer Immunotherapy and Biomarkers 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Co-authors
- Tao Wan (7 shared papers)Jiahong Dong (1 shared paper)Shichun Lu (10 shared papers)Hongguang Wang (4 shared papers)Wen Ma (1 shared paper)Honggang Nie (1 shared paper)Shuting Xu (1 shared paper)Yu Bai (1 shared paper)
- Journals
- Frontiers in Immunology (2 papers)Journal of Clinical Oncology (1 paper)Advanced Science (1 paper)BMC Surgery (1 paper)Hepatology International (1 paper)
- Partner nations
- ChinaPhilippinesRussia
In The Last Decade
Bingyang Hu
18 papers receiving 371 citations
Peers
Comparison fields: 5 of 46
- Hepatology 76
- Oncology 151
- Surgery 83
- Spectroscopy 33
- Pulmonary and Respiratory Medicine 55
Countries citing papers authored by Bingyang Hu
This map shows the geographic impact of Bingyang Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingyang Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingyang Hu more than expected).
Fields of papers citing papers by Bingyang Hu
This network shows the impact of papers produced by Bingyang Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingyang Hu. The network helps show where Bingyang Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bingyang Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 113 | |
| 2 | 2018 | 51 | |
| 3 | 2021 | 49 | |
| 4 | 2019 | 31 | |
| 5 | 2022 | 27 | |
| 6 | 2021 | 18 | |
| 7 | 2018 | 15 | |
| 8 | 2019 | 15 | |
| 9 | 2023 | 12 | |
| 10 | 2021 | 11 | |
| 11 | 2022 | 8 | |
| 12 | 2023 | 6 | |
| 13 | 2022 | 5 | |
| 14 | 2023 | 4 | |
| 15 | 2025 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2015 | 2 | |
| 18 | 2023 | 1 | |
| 19 | 2021 | 0 |
About Bingyang Hu
Bingyang Hu is a scholar working on Oncology, Hepatology, Molecular Biology, Pulmonary and Respiratory Medicine and Surgery, having authored 19 papers that have together received 373 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Ferroptosis and cancer prognosis (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Cancer Mechanisms and Therapy (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), RNA modifications and cancer (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Hepatology (76 citations), Oncology (151 citations), Surgery (83 citations), Spectroscopy (33 citations) and Pulmonary and Respiratory Medicine (55 citations). Bingyang Hu has collaborated with scholars based in China, Philippines and Russia. Frequent co-authors include Tao Wan, Jiahong Dong, Shichun Lu, Hongguang Wang, Wen Ma, Honggang Nie, Shuting Xu, Yu Bai, Huwei Liu and Zhanbo Wang. Their work appears in journals such as Frontiers in Immunology, Journal of Clinical Oncology, Advanced Science, BMC Surgery and Hepatology International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.